Trials / Conditions / Malignant Peripheral Nerve Sheath Tumor

Malignant Peripheral Nerve Sheath Tumor

11 registered clinical trials studyying Malignant Peripheral Nerve Sheath Tumor — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk T NCT06526897	ECOG-ACRIN Cancer Research Group	N/A
Recruiting	Neurofibromatosis Type 1 Tumor Early Detection Study NCT06515860	David Miller	—
Recruiting	Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma NCT04420975	Jonsson Comprehensive Cancer Center	Phase 1
Active Not Recruiting	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013	National Cancer Institute (NCI)	Phase 2
Completed	Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma NCT02584309	Washington University School of Medicine	Phase 2
Active Not Recruiting	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867	National Cancer Institute (NCI)	Phase 2 / Phase 3
Terminated	Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft T NCT01418001	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2
Completed	HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors NCT00931931	Timothy Cripe	Phase 1
Completed	Sorafenib and Dacarbazine in Soft Tissue Sarcoma NCT00837148	Memorial Sloan Kettering Cancer Center	Phase 2
Active Not Recruiting	Natural History Study of Patients With Neurofibromatosis Type I NCT00924196	National Cancer Institute (NCI)	—